NCT00555087View on ClinicalTrials.gov

Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate

PHASE4UnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2007

Study Completion Date

January 31, 2008

Conditions
Erectile DysfunctionHypogonadotrophic Males
Interventions
DRUG

Testosterone Undecanoate and/or PDE-5

Testosterone Undecanoate 1000 mg IM injection; PDF5 tab, 20 mg

Trial Locations (4)

44690

NOT_YET_RECRUITING

Hospital General de Occidente, Guadalajara

64460

NOT_YET_RECRUITING

Hospital Universitario de Nuevo León, Monterrey

06700

NOT_YET_RECRUITING

Hospital Santa Fe, Mexico City

045040

RECRUITING

Hospital General de Occidente, Guadalajara

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Hospital Santa Fe

OTHER